6860 Century Avenue, Suite 202
Mississauga, ON L5N 2W5
CEO: Antonella Rizza
Board Chair: Claudio Grossi

Charitable Reg. #:87346 1040 RR0001

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

[Charity Rating: 4/5]

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

B

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

69%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 69 cents are available for programs.



My anchor

OVERVIEW

About Lymphoma Canada:

Lymphoma Canada (LC) formed from a merger in 2000 between Lymphoma Research Foundation of Canada and Canadian Lymphoma Foundation, both of which were founded in 1998. Lymphoma Canada works to improve the lives of people affected by lymphoma. There are over 60 different types of cancers of the lymphatic system which affect over 100,000 Canadians. Doctors classify lymphoma into two general categories: Hodgkin and non-Hodgkin (NHL). Hodgkin lymphoma is rare, while NHL is the fifth most common cancer diagnosed in Canada. Lymphoma Canada runs four programs: Patient Education, Patient Support, Research, and Advocacy.
 
Patient Education accounted for 53% of Lymphoma Canada’s program spending in F2020. LC runs webinars and forums to keep patients and caregivers up to date on new treatment options, how to manage symptoms, and challenges that come with survivorship. LC hosted 11 educational webinars across Canada in 2020. LC also distributed over 3,500 patient resource manuals in F2020. Each manual details one of the three main subtypes of lymphoma.
 
Patient Support represents 36% of program spending in F2020. Peer-to-Peer Mentoring is a service offered through this program that matches lymphoma patients and caregivers to survivors. Lymphoma Canada also runs support groups. In 2020, LC relaunched an app, The CLL Watch & Wait, which allows patients to track Chronic Lymphocytic Leukemia (CLL) symptoms. In F2020, Lymphoma Canada also created a covid-19 hub to help guide lymphoma patients on covid related topics.
 
Research is Lymphoma Canada’s third largest program, accounting for 7% of program spending. LC awarded its Lymphoma Canada Research Grant to one research group in F2020. The recipients were Drs. Rob Laister and Sam Saibil from the Princess Margaret Cancer Centre. The researchers focus on CAR-T therapy, or Chimeric Antigen Receptor T cell therapy, a type of immunotherapy that modifies a patient’s T cells to better detect and destroy lymphoma.
 
Advocacy accounted for the final 4% of program costs in F2020. LC advocates for equal access to lymphoma treatments for all Canadians. In F2020, LC wrote letters to each of the provincial and territorial Ministers of Health advocating for equal access to CAR-T treatments across Canada.

My anchor

Results and Impact

Lymphoma Canada funded researchers who published a study in Nature Medicine in February 2020. The researchers discovered that diffuse large B-cell lymphoma cells with an altered gene respond better to lymphoma treatment.

While Ci highlights these key results, they may not be a complete representation of Lymphoma Canada’s results and impact. This charity is not yet rated on impact (n/r). 

My anchor

Finances

Lymphoma Canada has donations of $1.0m in F2020. The charity received $104k in government funding, representing 9% of total revenues. Administrative costs are 14% of revenues and fundraising costs are 17% of donations. This results in total overhead spending of 31%. For every dollar donated, 69 cents go to the cause. This is within Ci’s reasonable range for overhead spending.

Lymphoma Canada has $760k in funding reserves. The charity could cover 173% or almost one year and nine months of annual program costs with current reserves.

This charity report is an update that has been sent to Lymphoma Canada for review. Changes and edits may be forthcoming. 

Updated on July 5, 2021 by Brenleigh Jebb.  

Financial Review


Financial Ratios

Fiscal year ending December
202020192018
Administrative costs as % of revenues 14.1%21.5%39.3%
Fundraising costs as % of donations 17.0%29.1%34.5%
Total overhead spending 31.1%50.6%73.8%
Program cost coverage (%) 172.9%69.5%51.5%

Summary Financial Statements

All figures in $s
202020192018
Donations 1,017,7251,011,1381,452,791
Government funding 103,79330,41742,001
Other income 2,1337,5224,772
Total revenues 1,123,6511,049,0771,499,564
Program costs 420,142472,466447,471
Grants 19,600048,750
Administrative costs 158,615225,976588,859
Fundraising costs 172,572293,829501,749
Other costs 1,5734,72517,051
Total spending 772,502996,9961,603,880
Cash flow from operations 351,14952,081(104,316)
Capital spending 18,5414,5990
Funding reserves 760,163328,231255,668

Note: Ci reported direct research expenses as grants. Ci could not break out changes in government vs. non-government deferred contributions and therefore could not adjust for deferred donations. 

Salary Information

Full-time staff: 8

Avg. compensation: $53,850

Top 10 staff salary range:

$350k +
0
$300k - $350k
0
$250k - $300k
0
$200k - $250k
0
$160k - $200k
0
$120k - $160k
1
$80k - $120k
0
$40k - $80k
5
< $40k
2

Information from most recent CRA Charities Directorate filings for F2020

My anchor

Comments & Contact

Comments added by the Charity:

Charity Contact

Website: www.lymphoma.ca
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: (905) 858-5967

Print